Skip to content

    Alzheimer's Disease Health Center

    Font Size
    A
    A
    A

    Experimental Alzheimer's Drug Halted

    Drug Flurizan Didn't Meet Maker's Goals in Latest Tests
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    July 2, 2008 -- It's the end of the road for Flurizan, an experimental Alzheimer's disease drug, after disappointing results in its latest study.

    Myriad Genetics, which was developing Flurizan, says it's discontinuing work on the drug.

    In a preliminary study recently published in The Lancet, Flurizan looked like it might slow functional decline in Alzheimer's patients.

    But in Flurizan's latest study -- an 18-month trial in patients with mild Alzheimer's disease -- Flurizan didn't meet the researchers' benchmark for its effects on cognition (mental skills) and daily activities.

    Today on WebMD

    Remember your finger
    When it’s more than just forgetfulness.
    senior man with serious expression
    Which kinds are treatable?
     
    senior man
    Common symptoms to look for.
    mri scan of human brain
    Can drinking red wine reverse the disease?
     
    Checklist
    ARTICLE
    eating blueberries
    ARTICLE
     
    clock
    Article
    Colored mri of brain
    ARTICLE
     
    Human brain graphic
    ARTICLE
    mature woman
    ARTICLE
     
    Woman comforting ailing mother
    ARTICLE
    Senior woman with serious expression
    ARTICLE